Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F De Meyer

Showing results (41-50 of 155) with videos related to

Pageof 16
Sort By:
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Toward gene therapy for congenital thrombotic thrombocytopenic purpuraCharlotte Dekimpe, Elien Roose, Kazuya Sakai, et al.
Journal of the American Heart Association|January 26, 2018
Recombinant Human ADAMTS13 Treatment Improves Myocardial Remodeling and Functionality After Pressure Overload Injury in MiceThilo Witsch, Kimberly Martinod, Nicoletta Sorvillo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 26, 2012
Extracellular chromatin is an important mediator of ischemic stroke in miceSimon F De Meyer, Georgette L Suidan, Tobias A Fuchs, et al.
International Journal of Biometeorology|May 1, 1993
The periodicities in and biometeorological relationships with bed occupancy of an acute psychiatric ward in Antwerp, BelgiumM Maes, F De Meyer, D Peeters, et al.
Journal of Thrombosis and Haemostasis : JTH|August 29, 2018
Enhanced activity of an ADAMTS-13 variant (R568K/F592Y/R660K/Y661F/Y665F) against platelet agglutination in vitro and in a murine model of acute ischemic strokeK South, F Denorme, I I Salles-Crawley, et al.
Toxicon : Official Journal of the International Society on Toxinology|March 22, 2005
How does agkicetin-C bind on platelet glycoprotein Ibalpha and achieve its platelet effects?Gufeng Xu, Hans Ulrichts, Stephan Vauterin, et al.
Scientific Reports|November 11, 2018
von Willebrand factor deficiency does not influence angiotensin II-induced abdominal aortic aneurysm formation in miceIrina Portier, Kimberly Martinod, Linda Desender, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 5, 2015
Potential for Recombinant ADAMTS13 as an Effective Therapy for Acquired Thrombotic Thrombocytopenic PurpuraClaudia Tersteeg, Alexandra Schiviz, Simon F De Meyer, et al.
Expert Review of Hematology|November 20, 2015
ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategiesClaudia Tersteeg, Sebastien Verhenne, Elien Roose, et al.
Blood|September 11, 2009
Human platelets produced in nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice upon transplantation of human cord blood CD34(+) cells are functionally active in an ex vivo flow model of thrombosisIsabelle I Salles, Tim Thijs, Christine Brunaud, et al.
Pageof 16

Showing results (41-50 of 155) with videos related to

Sort By:
Pageof 16
Journal of Thrombosis and Haemostasis : JTH|January 25, 2023
Toward gene therapy for congenital thrombotic thrombocytopenic purpuraCharlotte Dekimpe, Elien Roose, Kazuya Sakai, et al.
Journal of the American Heart Association|January 26, 2018
Recombinant Human ADAMTS13 Treatment Improves Myocardial Remodeling and Functionality After Pressure Overload Injury in MiceThilo Witsch, Kimberly Martinod, Nicoletta Sorvillo, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|May 26, 2012
Extracellular chromatin is an important mediator of ischemic stroke in miceSimon F De Meyer, Georgette L Suidan, Tobias A Fuchs, et al.
International Journal of Biometeorology|May 1, 1993
The periodicities in and biometeorological relationships with bed occupancy of an acute psychiatric ward in Antwerp, BelgiumM Maes, F De Meyer, D Peeters, et al.
Journal of Thrombosis and Haemostasis : JTH|August 29, 2018
Enhanced activity of an ADAMTS-13 variant (R568K/F592Y/R660K/Y661F/Y665F) against platelet agglutination in vitro and in a murine model of acute ischemic strokeK South, F Denorme, I I Salles-Crawley, et al.
Toxicon : Official Journal of the International Society on Toxinology|March 22, 2005
How does agkicetin-C bind on platelet glycoprotein Ibalpha and achieve its platelet effects?Gufeng Xu, Hans Ulrichts, Stephan Vauterin, et al.
Scientific Reports|November 11, 2018
von Willebrand factor deficiency does not influence angiotensin II-induced abdominal aortic aneurysm formation in miceIrina Portier, Kimberly Martinod, Linda Desender, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|September 5, 2015
Potential for Recombinant ADAMTS13 as an Effective Therapy for Acquired Thrombotic Thrombocytopenic PurpuraClaudia Tersteeg, Alexandra Schiviz, Simon F De Meyer, et al.
Expert Review of Hematology|November 20, 2015
ADAMTS13 and anti-ADAMTS13 autoantibodies in thrombotic thrombocytopenic purpura - current perspectives and new treatment strategiesClaudia Tersteeg, Sebastien Verhenne, Elien Roose, et al.
Blood|September 11, 2009
Human platelets produced in nonobese diabetic/severe combined immunodeficient (NOD/SCID) mice upon transplantation of human cord blood CD34(+) cells are functionally active in an ex vivo flow model of thrombosisIsabelle I Salles, Tim Thijs, Christine Brunaud, et al.
Pageof 16